CN113005101A - F2 partially-deleted recombinant serum type 4 avian adenovirus and preparation method thereof - Google Patents

F2 partially-deleted recombinant serum type 4 avian adenovirus and preparation method thereof Download PDF

Info

Publication number
CN113005101A
CN113005101A CN202110332197.9A CN202110332197A CN113005101A CN 113005101 A CN113005101 A CN 113005101A CN 202110332197 A CN202110332197 A CN 202110332197A CN 113005101 A CN113005101 A CN 113005101A
Authority
CN
China
Prior art keywords
recombinant
avian adenovirus
gene
seq
virus
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202110332197.9A
Other languages
Chinese (zh)
Inventor
叶建强
谢泉
穆雅茹
秦爱建
邵红霞
万志敏
李拓凡
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Yangzhou University
Original Assignee
Yangzhou University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yangzhou University filed Critical Yangzhou University
Priority to CN202110332197.9A priority Critical patent/CN113005101A/en
Publication of CN113005101A publication Critical patent/CN113005101A/en
Pending legal-status Critical Current

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011Details
    • C12N2710/10011Adenoviridae
    • C12N2710/10211Aviadenovirus, e.g. fowl adenovirus A
    • C12N2710/10221Viruses as such, e.g. new isolates, mutants or their genomic sequences
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011Details
    • C12N2710/10011Adenoviridae
    • C12N2710/10211Aviadenovirus, e.g. fowl adenovirus A
    • C12N2710/10222New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2800/00Nucleic acids vectors
    • C12N2800/10Plasmid DNA
    • C12N2800/106Plasmid DNA for vertebrates

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

The invention relates to an F2 partial deletion type recombinant serum 4 avian adenovirus and a preparation method thereof, wherein a carrier framework of the recombinant serum 4 avian adenovirus is a wild type serum 4 avian adenovirus SD strain; according to the construction and application of the F2 partially deleted recombinant serotype 4 avian adenovirus based on the CRISPR-Cas9 technology, the currently popular serotype 4 avian adenovirus is selected as a framework, the functional region of interaction between the F2 gene and host protein in FAdV-4 is discovered and identified through silver staining, mass spectrometry, co-immunoprecipitation and other technologies, and then the F2 partially deleted recombinant FAdV-4 virus is successfully obtained after the functional region is deleted, and in-vivo and in-vitro experimental results show that the FA4-Del recombinant virus has significantly reduced toxicity and can provide good immune protection for SPF chickens.

Description

F2 partially-deleted recombinant serum type 4 avian adenovirus and preparation method thereof
Technical Field
The invention relates to an F2 partial deletion type recombinant serum 4-type avian adenovirus based on a CRISPR-Cas9 technology and a preparation method thereof, belonging to the technical field of genetic engineering.
Background
Avian Adenovirus (fowladenovirus, FAdV) belongs to the genus avian Adenovirus of the family adenoviridae, and is divided into 5 species (a-E), 12 serotypes. Although it has been reported all over the world that FAdV infection generally causes subclinical conditions, while acute infection mainly causes inclusion body hepatitis, pericardial effusion, and erosion of the muscle and stomach. In 2013, cases of inclusion body hepatitis and pericardial effusion caused by FAdV in domestic chicken flocks are gradually increased. By 2015, FAdV infections exploded in several provincial chicken flocks domestically. At present, FAdV outbreak occurs not only in broilers at the age of 3-4 weeks, but also in laying hens at the age of 10-20 weeks, which causes serious economic loss in the domestic chicken industry. Virus separation and identification find that the highly pathogenic 4-type FAdV has wide prevalence in domestic chicken flocks at present. However, no vaccine for FAdV-4 is currently available.
Previous researches report that the virulence of FAdV-4 is closely related to the F2 gene, so that the invention discovers and identifies the functional region of the interaction between the F2 gene and host protein in FAdV-4 by using a monoclonal antibody against F2 through silver staining, mass spectrum, co-immunoprecipitation and other technologies.
With the rapid development of gene editing technology in recent years, the application of the CRISPR-Cas9 technology is also more and more extensive. According to the invention, on the basis of obtaining the recombinant virus FAdV4-EGFP by the CRISPR-Cas9 technology at the earlier stage, the CRISPR-Cas9 technology is used again to edit the F2 gene, and then reverse screening is carried out to obtain the recombinant avian adenovirus lacking the F2 interaction functional region, and in-vivo and in-vitro experimental results show that the FA4-Del recombinant virus has significantly reduced toxicity, and the protection rate of the SPF chicken after challenge is up to 100%.
Disclosure of Invention
The invention aims to solve the problems and provides an F2 partially deleted recombinant serotype 4 avian adenovirus based on a CRISPR-Cas9 technology, a preparation method thereof and clinical application of the recombinant virus. The principle and the most central key technology of the invention are to identify the related functional region of F2, delete the functional region by using a gene editing technology, and obtain the high-purity attenuated F2 partially deleted recombinant serum type 4 avian adenovirus after purification.
The object of the invention is achieved in that,
an F2 partial deletion type recombinant avian adenovirus serotype 4 is characterized in that the carrier framework is a wild avian adenovirus serotype 4 SD strain;
the F2 partially-deleted recombinant serotype 4 avian adenovirus is obtained by editing an F2 gene through a CRISPR-Cas9 technology on the basis of an FAdV4-EGFP recombinant virus, wherein the sequence of the full-length F2 gene is shown as SEQ ID No. 1;
SEQ ID NO.1 is:
ATGCTCCGGGCCCCTAAAAGAAGACATTCCGAAAACGGGAAGCCCGAGACCGAAGCGGGACCTT CCCCGGCTCCAATCAAGCGCGCCAAACGCATGGTGAGAGCATCCCAGCTTGACCTGGTTTATCCTTTC GATTACGTGGCCGACCCCGTCGGAGGGCTCAACCCGCCTTTTTTGGGAGGCTCAGGACCCCTAGTGGA CCAGGGCGGACAGCTTACGCTCAACGTCACCGATCCCATCATCATCAAGAACAGATCGGTGGACTTGG CCCACGACCCCAGTCTCGATGTCAACGCCCAAGGTCAACTGGCGGTGGCCGTTGACCCCGAAGGGGCC CTGGACATCACCCCCGATGGACTGGACGTCAAGGTCGACGGAGTGACCGTAATGGTCAACGATGACTG GGAACTGGCCGTAAAAGTCGACCCGTCCGGCGGATTGGATtCCACCGCGGGTGGACTGGGGGTCAGCG TGGACGACACCTTGCTCGTGGATCAGGGAGAACTGGGCGTACACCTCAACCAACAAGGACCCATCACT GCCGATAGCAGTGGTATCGACCTCGAGATCAATCCTAACATGTTCACGGTCAACACCTCGACCGGAAG CGGAGTGCTGGAACTCAACCTAAAAGCGCAGGGAGGCATCCAAGCCGACAGTTCGGGAGTGGGCGTTT CCGTGGATGAAAGCCTACAGATTGTCAACAACACTCTGGAAGTGAAACCGGATCCCAGCGGACCGCTT ACGGTCTCCGCCAATGGCCTAGGGCTGAAGTACGACACTAATACCCTAGCGGTGACCGCGGGCGCTTT AACCGTGGTCGGAGGGGGGAGCGTCTCCACACCCATCGCTACTTTTGTCTCGGGAAGTCCCAGCCTCA ACACCTACAATGCCACGACCGTCAATTCCAGCGCGAACGCCTTCTCTTGCGCCTACTACCTTCAACAG TGGAACATACAGGGGCTCCTTGTTACCTCCCTCTACTTGAAATTGGACAGCGCCACCATGGGGAATCG CCCTGGGGACCTCAACTCCGCCAATGCCAAATGGTTCACCTTTTGGGTGTCCGCCTATCTCCAGCAAT GCAACCCCTCCGGGATTCAAGCGGGAACGGTCAGCCCCTCCACCGCCACCCTCACGGACTTTGAACCC ATGGCCAATAGGAGCGTGACCAGCCCATGGACGTACTCGGCCAATGGATACTATGAACCATCCATCGG GGAATTCCAAGTGTTCAGCCCGGTGGTAACAGGTGCCTGGAACCCGGGAAACATAGGGATCCGCGTCC TCCCCGTGCCGGTTTCGGCCTCCGGAGAGCGATACACCCTTCTATGCTATAGTCTGCAGTGCACGAAC GCGAGCATTTTTAATCCAAACAACAGCGGAACCATGATCGTGGGACCCGTGCTCTACAGCTGTCCAGC GGCCTCCCTCCCGTAA。
the partial gene of the deletion F2 is characterized in that the amino acids at positions 7-40 of F2 are identified as functional regions interacting with host protein by silver staining, mass spectrometry, co-immunoprecipitation and other technologies, and the sequence of the partial gene of F2 is shown as SEQ ID NO.2 after the deletion;
SEQ ID NO.2 is:
ATGCTCCGGGCCCCTAAAGTTTATCCTTTCGATTACGTGGCCGACCCCGTCGGAGGGCTCAACC CGCCTTTTTTGGGAGGCTCAGGACCCCTAGTGGACCAGGGCGGACAGCTTACGCTCAACGTCACCGAT CCCATCATCATCAAGAACAGATCGGTGGACTTGGCCCACGACCCCAGTCTCGATGTCAACGCCCAAGG TCAACTGGCGGTGGCCGTTGACCCCGAAGGGGCCCTGGACATCACCCCCGATGGACTGGACGTCAAGG TCGACGGAGTGACCGTAATGGTCAACGATGACTGGGAACTGGCCGTAAAAGTCGACCCGTCCGGCGGA TTGGATtCCACCGCGGGTGGACTGGGGGTCAGCGTGGACGACACCTTGCTCGTGGATCAGGGAGAACT GGGCGTACACCTCAACCAACAAGGACCCATCACTGCCGATAGCAGTGGTATCGACCTCGAGATCAATC CTAACATGTTCACGGTCAACACCTCGACCGGAAGCGGAGTGCTGGAACTCAACCTAAAAGCGCAGGGA GGCATCCAAGCCGACAGTTCGGGAGTGGGCGTTTCCGTGGATGAAAGCCTACAGATTGTCAACAACAC TCTGGAAGTGAAACCGGATCCCAGCGGACCGCTTACGGTCTCCGCCAATGGCCTAGGGCTGAAGTACG ACACTAATACCCTAGCGGTGACCGCGGGCGCTTTAACCGTGGTCGGAGGGGGGAGCGTCTCCACACCC ATCGCTACTTTTGTCTCGGGAAGTCCCAGCCTCAACACCTACAATGCCACGACCGTCAATTCCAGCGC GAACGCCTTCTCTTGCGCCTACTACCTTCAACAGTGGAACATACAGGGGCTCCTTGTTACCTCCCTCT ACTTGAAATTGGACAGCGCCACCATGGGGAATCGCCCTGGGGACCTCAACTCCGCCAATGCCAAATGG TTCACCTTTTGGGTGTCCGCCTATCTCCAGCAATGCAACCCCTCCGGGATTCAAGCGGGAACGGTCAG CCCCTCCACCGCCACCCTCACGGACTTTGAACCCATGGCCAATAGGAGCGTGACCAGCCCATGGACGT ACTCGGCCAATGGATACTATGAACCATCCATCGGGGAATTCCAAGTGTTCAGCCCGGTGGTAACAGGT GCCTGGAACCCGGGAAACATAGGGATCCGCGTCCTCCCCGTGCCGGTTTCGGCCTCCGGAGAGCGATA CACCCTTCTATGCTATAGTCTGCAGTGCACGAACGCGAGCATTTTTAATCCAAACAACAGCGGAACCA TGATCGTGGGACCCGTGCTCTACAGCTGTCCAGCGGCCTCCCTCCCGTAA。
the host protein interacting with the F2 protein is KPNA3 and KPNA4 protein, and the gene sequence is shown in SEQ ID NO.3 and SEQ ID NO. 4;
SEQ ID NO.3 is:
ATGGCCGAGAACGCCGCCGCCGGCCTGGAGAACCACCGCATCAAGAGCTTCAAGAACAAGGGCC GCGACGTGGAGACTATGAGGAGACACAGAAACGAAGTTACAATTGAATTGAGGAAGAACAAAAGAGAT GAACATCTTTTGAAAAAACGAAACGTTCCCCAAGAAGAAAGTTTAGAAGATTCTGATGTTGATGCTGA CTTCAAAGCACAAAACGTAACACTAGAAGCTATACTGCAGAACGCCACAAGTGACAACCCAGTGATCC AACTGAGTGCTGTTCAAGCTGCAAGAAAACTCCTATCCAGTGACAGAAATCCACCTATTGATGACTTA ATAAAATCTGGAATTTTGCCAATTCTGGTAAAATGCCTAGAAAGGGATGATAATCCTTCATTACAATT TGAAGCTGCATGGGCATTGACTAACATAGCATCAGGCACTTCTGCACAAACTCAAGCTGTTGTACAGT CTAATGCAGTACCCCTCTTTTTGAGACTACTCCATTCTCCGCACCAGAACGTTTGTGAGCAGGCTGTG TGGGCCCTCGGAAATATCATTGGTGATGGTCCTCAGTGTAGAGATTATGTCATATCACTGGGAGTTGT CAAACCTCTTCTGTCCTTCATCAATCCCTCCATTCCCATCACCTTCCTTCGGAACGTCACATGGGTCA TTGTAAATCTCTGCAGGAATAAGGACCCCCCACCGCCTATGGAGACAGTTCAGGAGATTTTGCCAGCA TTGTGTGTTCTCATTTACCATACAGATATAAACATTCTCGTGGACACCGTTTGGGCTTTGTCCTACTT AACAGACGGTGGCAACGAGCAGATACAGATGGTGATTGATTCGGGAGTTGTACCTTTTCTAGTTCCCC TTCTGAGTCACCAGGAGGTCAAAGTTCAGACAGCAGCACTGAGAGCAGTAGGCAACATAGTAACCGGT ACCGATGAACAGACACAAGTTGTTCTCAACTGTGATGTTTTGTCTTACTTCCCAAACCTCCTGACGCA TCCAAAAGAGAAGATAAACAAGGAAGCAGTTTGGTTCCTTTCCAATATCACAGCAGGAAACCAGCAAC AAGTTCAGGCTGTAATAGATGCTGGGCTAATCCCTATGATCATACACCAGCTGGCTAAGGGTGACTTT GGAACACAGAAGGAAGCTGCTTGGGCAATTAGCAATTTGACAATAAGTGGGAGAAAAGATCAGGTTGA ATACCTTGTACAGCAAAACGTAATCCCACCATTCTGCAATCTACTCTCAGTAAAGGATTCTCAAGTGG TGCAGGTGGTGCTGGATGGTCTGAAAAACATCCTGATAATGGCTGGTGATGAGGCTAGCACAATAGCT GAAATTATAGAAGAGTGTGGAGGGTTAGAGAAAATTGAAGCCTTGCAACAACATGAGAATGAAGACAT TTATAAACTAGCGTTTGAAATCATAGATCAATATTTCTCTGGTGATGATATCGATGAGGATCCCAGTC TCATTCCTGAAGCCACTCAAGGAGGTACTTACAATTTTGACCCGACAGCCAACCTTCAAACAAAAGAA TTTAATTTTTAA;
SEQ ID NO.4 is:
ATGGCCGACAACGAGAAACTGGACAACCAGCGGCTGAAGAACTTCAAGAACAAAGGCCGCGACC TGGAGACTATGAGAAGACAAAGGAATGAAGTTGTCGTGGAGTTGAGAAAGAACAAAAGAGACGAACAT CTTCTAAAGAGGAGGAATGTACCCCATGAGGATATCTGTGAAGATTCCGACGTAGATGGTGACTTCAG AGTGCAAAACACTTCTTTGGAAGCAATAGTACAGAATGCTTCAAGTGACAACCAGGGTATACAGTTAA GTGCTGTGCAAGCTGCAAGAAAACTGCTTTCCAGTGATCGCAATCCACCAATTGATGATCTAATAAAA TCAGGAATATTACCTATTCTAGTGCACTGTCTTGAAAGAGATGACAATCCTTCTTTACAGTTTGAAGC TGCATGGGCTTTGACAAACATTGCATCTGGAACCTCTGAACAAACACAGGCCGTGGTTCAATCTAATG CTGTACCACTTTTTCTGAGACTGCTGCATTCACCTCACCAAAATGTTTGTGAACAAGCTGTGTGGGCT TTAGGCAATATCATAGGTGATGGACCCCAGTGTAGAGATTACGTTATTAGTCTTGGAGTAGTGAAACC ACTGCTGTCCTTCATCAGCCCATCTATTCCCATAACTTTCTTAAGAAACGTTACTTGGGTCATGGTCA ACTTGTGCCGTCACAAAGATCCTCCTCCGCCCATGGAAACCATTCAGGAGATCCTTCCAGCCCTCTGT GTTTTAATTCACCACACAGATGTAAATATATTGGTAGATACAGTCTGGGCACTCTCATATCTAACGGA TGCTGGCAATGAACAGATCCAGATGGTGATAGACTCCGGAATAGTCCCTCATTTGGTTCCTCTTCTCA GTCATCAAGAAGTGAAAGTGCAGACTGCTGCGCTGAGAGCGGTAGGAAACATTGTCACTGGTACCGAT GAGCAGACACAGGTAGTTCTGAATTGTGAAGCTCTTTCACATTTCCCAGCACTTCTGACACATCCCAA AGAAAAAATTAATAAGGAAGCAGTGTGGTTTCTATCTAACATCACTGCAGGAAATCAGCAGCAAGTTC AGGCAGTAATAGATGCAAACCTTGTTCCAATGATAATACATCTTCTAGATAAGGGTGACTTTGGTACT CAGAAAGAAGCTGCTTGGGCAATAAGCAATTTAACAATCAGCGGAAGAAAAGACCAAGTGGCATACTT AATTCAACAAAACGTAATTCCTCCCTTTTGCAATTTGCTAACAGTAAAAGATGCACAAGTTGTGCAAG TGGTTCTGGATGGACTAAGTAATATATTAAAAATGGCTGAAGATGAAGCAGAAACCATAGCCAATCTT ATTGAAGAGTGCGGAGGCCTGGAGAAAATTGAACAGCTACAAAACCATGAAAATGAAGACATCTACAA ACTGGCTTATGAGATCATTGATCAGTTCTTCTCTTCAGATGATATTGATGAAGATCCTAGCCTTGTAC CGGAAGCAATACAAGGCGGAACATTTGGTTTCAATTCATCTGCCAATGTACCAGCAGAAGGGTTCCAG TTTTAG。
a preparation method of F2 partial deletion type recombinant serotype 4 avian adenovirus comprises the following steps:
(1) designing sgRNAs at the downstream positions of Fiber 1 gene and Fiber2 gene by utilizing an sgRNA online design website, and selecting the sgRNAs with higher scores and higher ranks, wherein the sequences of the sgRNAs are shown in Table 1;
TABLE 1 sgRNA sequences for Fiber 1 and Fiber2 genes
Figure BDA0002996565620000051
(2) Constructing a donor plasmid with a part of the Fiber2 gene deleted by overlap-PCR, wherein the sequences of primers used in the overlap-PCR are shown in Table 2;
TABLE 2 PCR sequences used for construction of Donor plasmids
Figure BDA0002996565620000052
Figure BDA0002996565620000061
(3) Paving LMH cells one day before transfection, transfecting two sgRNAs and donor plasmids each by 2ug on the next day, and replacing with 10% growth solution after transfecting for 6 h;
(4) infection with FAdV4-EGFP is carried out 24h after transfection, and 1% maintenance fluid is changed 2h later;
(5) after FAdV4-EGFP infection, indirect immunofluorescence and limiting dilution are used for purification, and the deletion type recombinant FAdV4 virus with a F2 partial functional region deleted is obtained.
The LMH cell line is chicken liver cancer cell.
According to the construction and application of the F2 partial deletion type recombinant serum 4-type poultry adenovirus, the currently popular serum 4-type poultry adenovirus is selected as a framework, a functional region of interaction between an F2 gene and host protein in FAdV-4 is discovered and identified through silver staining, mass spectrometry, co-immunoprecipitation and other technologies, and then the F2 partial deletion type recombinant FAdV-4 virus is successfully obtained after the functional region is deleted.
Drawings
FIG. 1 shows WB to verify that F2 mAb can pull down KPNA3 and KPNA 4.
FIG. 2 shows WB demonstrating that KPNA3 and KPNA4 have multiple tensile strengths to pull down F2.
FIG. 3 shows that overexpression of KPNA3/4 promotes viral replication.
FIG. 4 shows that knock-out of KPNA3/4 inhibits viral replication.
FIG. 5 is an epitope identification of F2 interacting with KPNA 3/4.
FIG. 6 shows PCR amplification of linearized HR1-F2(d7-40aa) -HR 2.
FIG. 7 is a schematic diagram of a construction strategy of a deletion type recombinant virus FA 4-Del.
FIG. 8 shows the identification of deletion type recombinant virus FA4-Del before and after purification by PCR.
FIG. 9 is a graph plotting the growth curve of recombinant virus FA 4-Del.
FIG. 10 is a graph showing the survival of SPF flocks infected with FA4-Del recombinant virus and FAdV-4 virus.
FIG. 11 shows detoxification of SPF flocks infected with virus.
FIG. 12 is a graph showing survival of a surviving flock of chickens after challenge with FAdV-4.
Detailed Description
Example (b):
1, poultry adenovirus separation, namely taking the liver of a suspected poultry adenovirus infected chicken died of illness, grinding the liver, and adding PBS (phosphate buffer solution) into the ground liver according to the proportion of 1:5 to prepare suspension; centrifuging at 5000r/min for 15min, and collecting supernatant; adding 1000IU/ml of each of penicillin and streptomycin, and reacting for 30min at 37 ℃; filtering with 0.45um microporous filter, inoculating SPF chick embryo of 8 days old via allantoic cavity at a dose of 0.2 ml/embryo, and collecting allantoic fluid 96-120 hr after inoculation; allantoic fluid was identified as avian adenovirus and stored at-20 ℃.
2, preparing the genome of the avian adenovirus: taking 400uL of poultry adenovirus isolate strain virus supernatant into a 1.5mL finger tube, adding 400uL of cell lysate (50mmol/L Tris-HCl pH 8.0, 20mmol/L EDTA pH 8.0, 2% SDS and proteinase K), fully mixing uniformly, and placing in a 56 ℃ water bath for acting for 4 hours; adding 400uLTris balance phenol, fully and uniformly mixing, centrifuging for 10 minutes at 10000r/min, and taking the supernatant in another 1.5mL finger-shaped tube; add 400uL phenol: chloroform: isoamyl alcohol, centrifuging at 10000r/min for 5 minutes after fully mixing, and taking the supernatant in another 1.5mL finger-shaped tube; adding 800uL of absolute ethyl alcohol, reversing, uniformly mixing, putting into the mixture, incubating for 30 minutes at the temperature of minus 20 ℃, centrifuging for 15 minutes at the speed of 12000r/min, and removing the supernatant; naturally drying at room temperature, adding 30uL sterilized ultrapure water and 2uLRNA enzyme into the precipitate, fully dissolving to obtain the serum 4 type avian adenovirus genome, and standing at-20 deg.C for use.
3, co-immunoprecipitation identifies the interaction of F2 with the host protein KPNA 3/4: the interaction with the FAdV-4 virus F2 protein and the host protein KPNA3/4 is discovered in the early laboratory through performing Co-IP, silver staining, mass spectrum sequencing and the like on the F2 monoclonal antibody. Then, WB identification was performed by Co-IP. Firstly, infecting LMH cells with FAdV-4, collecting the cells after 72 hours, cracking, centrifuging, removing a cracked supernatant, adding F2 monoclonal antibody 3C2, incubating overnight, adding protein G agarose for enriching antibodies the next day, adding protein loading buffer solution for boiling after washing, and then performing WB verification by using multiple antibodies of KPNA3 or KPNA4, as shown in FIG. 1, a specific band can be obviously seen, which indicates that KPNA3 or KPNA4 can be pulled down by F2; secondly, LMH cells were transfected with plasmids F1 and F2, respectively, lysed and then Co-IP was performed by adding either KPNA3 or a polyclonal antibody to KPNA4, followed by a FAdV-4 positive serum test, as shown in FIG. 2, where F2 was pulled down by KPNA 3/4. Two WB results indicated the interaction between F2 and KPNA 3/4.
4, KPNA3/4 promotes viral replication: firstly cloning KPNA3/4 gene of chicken into eukaryotic expression vector pcDNA3.1, then transfecting KPNA3/4 gene in LMH cell, infecting FAdV-4 with 0.01MOI after transfecting for 24h, respectively collecting cell supernatant at 24h, 48h, 72h, 96h and 120h time points, and detecting the influence of over-expression KPNA3/4 on virus replication (as shown in figure 3); on the other hand, KPNA3/4 genes are knocked out by using a CRISPR-Cas9 technology, and LMH cell lines of KPNA3-KO and KPNA4-KO are obtained. KPNA3-KO and KPNA4-KO cells were infected with 0.01MOI of FAdV-4, respectively, and cell supernatants were collected at 24h, 48h, 72h, 96h and 120h time points, respectively, to examine the effect of KPNA3/4-KO on virus replication (see FIG. 4). It can be seen that overexpression of KPNA3/4 promotes viral replication, whereas deletion of KPNA3/4 inhibits viral replication. Indicating that FAdV-4 can promote virus replication by using KPNA3/4 gene.
5, epitope identification of F2 interaction with KPNA 3/4: different F2 truncations are constructed at the early stage, after LMH cells are transfected, the cells are collected after 48 hours for lysis, then F2 monoclonal antibody 3C2 is added into the supernatant of the lysed cells for Co-IP, and finally the interaction epitope of F2 is locked in two regions of 7-40aa and 61-114aa continuously through Co-IP. As shown in FIG. 5, WB results show that F2 with full length and F2-del61_114aa pulled KPNA3/4 well, while F2-del7_40aa did not, indicating that the epitope for F2 interacting with KPNA3/4 falls between 7-40aa of F2.
6, design and construction of sgRNA: sgRNA sequence design was performed using the sgRNA on-line design website (http:// crispr-era. stanford. edu/index. jsp and http:// crispr. mit. edu) based on the genes of KPNA3/4, Fiber 1 and Fiber 2. The designed sgRNAs are respectively cloned to lentiCRISPR v2 plasmids, and the construction is successful through sequencing verification: specific sgRNA sequences are shown in table 1 and were synthesized by jinzhi biotechnology, su.
TABLE 1 sgRNA sequences for Fiber 1 and Fiber2 genes
Figure BDA0002996565620000081
7, construction of donor plasmid with deletion of F2 partial gene: a primer is designed by taking a circular HR1-EGFP-F2-HR2 donor plasmid as a template for PCR amplification, 7-40aa of EGFP gene and F2 are deleted to obtain a linearized HR1-F2(del7-40aa) -HR2 (as shown in figure 6), and homologous recombination self-ligation is carried out after gel recovery to obtain a circular HR1-F2(del7-40aa) -HR2 donor plasmid. Wherein the HR1-EGFP-F2-HR2 fragment has the sequence shown in SEQ ID NO. 9. The sequences of the primers used to construct the donor plasmids are shown in Table 2.
TABLE 2 PCR sequences used for construction of Donor plasmids
Figure BDA0002996565620000091
8, rescue of recombinant FA4-Del virus: paving LMH cells in a 6-well plate one day before transfection, wherein each well contains 120-150w cells; the next day the cell density was grown to around 80% to prepare for transfection, 2 sgrnas and donor plasmids each at 2ug, using 2uL transfection reagent Mirus with 1ug plasmid 2: 1 for 45min at room temperature, and after the incubation, the transfection reagent and plasmid mixture was added dropwise to cells previously covered with Opti-MEM for transfection, and the cells were changed to 10% growth medium 6h after transfection. After transfection for 48h, growth medium was discarded, LMH cells were infected with 0.1MOI of FAdV4-EGFP, and after 2h infection, virus was discarded and replaced with 1% maintenance medium. The construction scheme of the present invention is shown in FIG. 7. After infection with the virus, the virus is purified by a limiting dilution method, IFA method or the like.
9, purification and identification of recombinant FA4-Del virus: infecting rescued recombinant FA4-Del virus in a 96-well plate paved with LMH, fixing the plate after 72h, taking F2 monoclonal antibody as a primary antibody, taking PE-labeled goat anti-mouse as a secondary antibody, selecting the supernatant in the hole with less green fluorescence and more red light to inoculate a 12-well plate, selecting the hole with more recombinant virus after PCR identification to carry out subsequent purification, and continuously repeating the purification steps until the high-purity recombinant virus is obtained (as shown in figure 8), wherein primers used for PCR are shown in Table 3.
TABLE 3 primers for PCR amplification identification of recombinant viruses
Figure BDA0002996565620000092
Figure BDA0002996565620000101
10, plotting of the in vitro growth curve of the recombinant FA4-Del virion: rescued recombinant FA4-Del and wild-type FAdV-4 were inoculated in LMH-plated 6-well plates at 0.1MOI, virus supernatants were harvested at 24h, 48h, 72h, 96h and 120h, respectively, after inoculation, and virus titers in the supernatants were determined using TCID50 (see fig. 9). The results show that the replication curves of the recombinant virus FA4-Del are similar to those of FAdV-4, but the replication speed of the recombinant virus is obviously slower, and the highest titer is about 100 times lower than that of the FAdV-4.
11, evaluation of pathogenicity of recombinant FA4-Del virus in vivo: 120 SPF chickens at 2 weeks of age were randomized into 3 groups, namely FA4-Del group, FAdV-4 group and control group, followed by 2.5X 106TCID50The chicken flocks were inoculated with doses of recombinant virus FA4-Del and FAdV-4, and the control group was injected with the same volume of 1% cell maintenance solution. After infection with virus, the growth of the flock was observed daily and morbidity and mortality were recorded. After 14 days, survival curves were plotted (see FIG. 10), and it was found that the chickens infected with wild-type FAdV-4 virus had sleepiness, depression, wing droop, etc. on the first day after infectionSymptoms; a few deaths of SPF chickens were observed the next day after infection, with flock deaths mainly concentrated on the third day after infection and all deaths on the fourth day after infection. In contrast, the FA4-Del virus-infected chicken flock and the control chicken flock were all alive. In the second, fourth and fifth days after virus infection, 3 chickens in each group are respectively killed, and the dissecting finds that the chickens infected with wild type FAdV-4 have typical hepatitis-pericardial effusion syndrome; the chicken flocks infected with FA4-Del and the chicken flocks of the control group have no symptoms at all. Pathological observation is carried out on the dissected chicken flocks, and the liver of the chicken flocks infected with FAdV-4 is found to have typical intranuclear inclusion bodies; while the liver was completely normal in the chicken flocks infected with FA4-Del and the chicken flocks of the control group. The swab test was carried out on 3 groups of chickens (see FIG. 11), and it was found that the chickens infected with FAdV-4 virus were detoxified in a large amount, while the chickens infected with FA4-Del virus were not detoxified at all the test time points. The above results indicate that the pathogenicity of the recombinant virus FA4-Del constructed in the present invention is significantly attenuated compared to wild-type FAdV-4.
12, FA4-Del recombinant virus challenge protection test: the chickens infected with FA4-Del recombinant virus and the chickens of the control group still survive after 21 days, then the challenge protection experiment is carried out on the surviving chickens, and both groups of chickens challenge 106TCID50Dose of FAdV-4. After challenge, the growth of the chicken flocks was observed every day, and the morbidity and mortality were recorded. Survival curves were plotted after 14 days (see fig. 12), and the results showed that the mortality rate reached 80% within 6 days after challenge with FAdV-4 in the control group; in contrast, the mortality rate of the chicken flocks infected with the FA4-Del recombinant virus after challenge was 0, and no virus was detected in the liver, spleen and kidney. The FA4-Del recombinant virus constructed by the invention can provide complete protection for chicken flocks.
SEQ ID NO.1
Avian adenovirus Fiber2 gene sequence:
ATGCTCCGGGCCCCTAAAAGAAGACATTCCGAAAACGGGAAGCCCGAGACCGAAGCGGGACCTT CCCCGGCTCCAATCAAGCGCGCCAAACGCATGGTGAGAGCATCCCAGCTTGACCTGGTTTATCCTTTC GATTACGTGGCCGACCCCGTCGGAGGGCTCAACCCGCCTTTTTTGGGAGGCTCAGGACCCCTAGTGGA CCAGGGCGGACAGCTTACGCTCAACGTCACCGATCCCATCATCATCAAGAACAGATCGGTGGACTTGG CCCACGACCCCAGTCTCGATGTCAACGCCCAAGGTCAACTGGCGGTGGCCGTTGACCCCGAAGGGGCC CTGGACATCACCCCCGATGGACTGGACGTCAAGGTCGACGGAGTGACCGTAATGGTCAACGATGACTG GGAACTGGCCGTAAAAGTCGACCCGTCCGGCGGATTGGATtCCACCGCGGGTGGACTGGGGGTCAGCG TGGACGACACCTTGCTCGTGGATCAGGGAGAACTGGGCGTACACCTCAACCAACAAGGACCCATCACT GCCGATAGCAGTGGTATCGACCTCGAGATCAATCCTAACATGTTCACGGTCAACACCTCGACCGGAAG CGGAGTGCTGGAACTCAACCTAAAAGCGCAGGGAGGCATCCAAGCCGACAGTTCGGGAGTGGGCGTTT CCGTGGATGAAAGCCTACAGATTGTCAACAACACTCTGGAAGTGAAACCGGATCCCAGCGGACCGCTT ACGGTCTCCGCCAATGGCCTAGGGCTGAAGTACGACACTAATACCCTAGCGGTGACCGCGGGCGCTTT AACCGTGGTCGGAGGGGGGAGCGTCTCCACACCCATCGCTACTTTTGTCTCGGGAAGTCCCAGCCTCA ACACCTACAATGCCACGACCGTCAATTCCAGCGCGAACGCCTTCTCTTGCGCCTACTACCTTCAACAG TGGAACATACAGGGGCTCCTTGTTACCTCCCTCTACTTGAAATTGGACAGCGCCACCATGGGGAATCG CCCTGGGGACCTCAACTCCGCCAATGCCAAATGGTTCACCTTTTGGGTGTCCGCCTATCTCCAGCAAT GCAACCCCTCCGGGATTCAAGCGGGAACGGTCAGCCCCTCCACCGCCACCCTCACGGACTTTGAACCC ATGGCCAATAGGAGCGTGACCAGCCCATGGACGTACTCGGCCAATGGATACTATGAACCATCCATCGG GGAATTCCAAGTGTTCAGCCCGGTGGTAACAGGTGCCTGGAACCCGGGAAACATAGGGATCCGCGTCC TCCCCGTGCCGGTTTCGGCCTCCGGAGAGCGATACACCCTTCTATGCTATAGTCTGCAGTGCACGAAC GCGAGCATTTTTAATCCAAACAACAGCGGAACCATGATCGTGGGACCCGTGCTCTACAGCTGTCCAGC GGCCTCCCTCCCGTAA
SEQ ID NO.2
fiber2 gene sequence deleted of the interacting epitope: ATGCTCCGGGCCCCTAAAGTTTATCCTTTCGATTACGTGGCCGACCCCGTCGGAGGGCTCAACCCGCC TTTTTTGGGAGGCTCAGGACCCCTAGTGGACCAGGGCGGACAGCTTACGCTCAACGTCACCGATCCCA TCATCATCAAGAACAGATCGGTGGACTTGGCCCACGACCCCAGTCTCGATGTCAACGCCCAAGGTCAA CTGGCGGTGGCCGTTGACCCCGAAGGGGCCCTGGACATCACCCCCGATGGACTGGACGTCAAGGTCGA CGGAGTGACCGTAATGGTCAACGATGACTGGGAACTGGCCGTAAAAGTCGACCCGTCCGGCGGATTGG ATtCCACCGCGGGTGGACTGGGGGTCAGCGTGGACGACACCTTGCTCGTGGATCAGGGAGAACTGGGC GTACACCTCAACCAACAAGGACCCATCACTGCCGATAGCAGTGGTATCGACCTCGAGATCAATCCTAA CATGTTCACGGTCAACACCTCGACCGGAAGCGGAGTGCTGGAACTCAACCTAAAAGCGCAGGGAGGCA TCCAAGCCGACAGTTCGGGAGTGGGCGTTTCCGTGGATGAAAGCCTACAGATTGTCAACAACACTCTG GAAGTGAAACCGGATCCCAGCGGACCGCTTACGGTCTCCGCCAATGGCCTAGGGCTGAAGTACGACAC TAATACCCTAGCGGTGACCGCGGGCGCTTTAACCGTGGTCGGAGGGGGGAGCGTCTCCACACCCATCG CTACTTTTGTCTCGGGAAGTCCCAGCCTCAACACCTACAATGCCACGACCGTCAATTCCAGCGCGAAC GCCTTCTCTTGCGCCTACTACCTTCAACAGTGGAACATACAGGGGCTCCTTGTTACCTCCCTCTACTT GAAATTGGACAGCGCCACCATGGGGAATCGCCCTGGGGACCTCAACTCCGCCAATGCCAAATGGTTCA CCTTTTGGGTGTCCGCCTATCTCCAGCAATGCAACCCCTCCGGGATTCAAGCGGGAACGGTCAGCCCC TCCACCGCCACCCTCACGGACTTTGAACCCATGGCCAATAGGAGCGTGACCAGCCCATGGACGTACTC GGCCAATGGATACTATGAACCATCCATCGGGGAATTCCAAGTGTTCAGCCCGGTGGTAACAGGTGCCT GGAACCCGGGAAACATAGGGATCCGCGTCCTCCCCGTGCCGGTTTCGGCCTCCGGAGAGCGATACACC CTTCTATGCTATAGTCTGCAGTGCACGAACGCGAGCATTTTTAATCCAAACAACAGCGGAACCATGAT CGTGGGACCCGTGCTCTACAGCTGTCCAGCGGCCTCCCTCCCGTAA
SEQ ID NO.3
Chicken KPNA3 gene sequence:
ATGGCCGAGAACGCCGCCGCCGGCCTGGAGAACCACCGCATCAAGAGCTTCAAGAACAAGGGCC GCGACGTGGAGACTATGAGGAGACACAGAAACGAAGTTACAATTGAATTGAGGAAGAACAAAAGAGAT GAACATCTTTTGAAAAAACGAAACGTTCCCCAAGAAGAAAGTTTAGAAGATTCTGATGTTGATGCTGA CTTCAAAGCACAAAACGTAACACTAGAAGCTATACTGCAGAACGCCACAAGTGACAACCCAGTGATCC AACTGAGTGCTGTTCAAGCTGCAAGAAAACTCCTATCCAGTGACAGAAATCCACCTATTGATGACTTA ATAAAATCTGGAATTTTGCCAATTCTGGTAAAATGCCTAGAAAGGGATGATAATCCTTCATTACAATT TGAAGCTGCATGGGCATTGACTAACATAGCATCAGGCACTTCTGCACAAACTCAAGCTGTTGTACAGT CTAATGCAGTACCCCTCTTTTTGAGACTACTCCATTCTCCGCACCAGAACGTTTGTGAGCAGGCTGTG TGGGCCCTCGGAAATATCATTGGTGATGGTCCTCAGTGTAGAGATTATGTCATATCACTGGGAGTTGT CAAACCTCTTCTGTCCTTCATCAATCCCTCCATTCCCATCACCTTCCTTCGGAACGTCACATGGGTCA TTGTAAATCTCTGCAGGAATAAGGACCCCCCACCGCCTATGGAGACAGTTCAGGAGATTTTGCCAGCA TTGTGTGTTCTCATTTACCATACAGATATAAACATTCTCGTGGACACCGTTTGGGCTTTGTCCTACTT AACAGACGGTGGCAACGAGCAGATACAGATGGTGATTGATTCGGGAGTTGTACCTTTTCTAGTTCCCC TTCTGAGTCACCAGGAGGTCAAAGTTCAGACAGCAGCACTGAGAGCAGTAGGCAACATAGTAACCGGT ACCGATGAACAGACACAAGTTGTTCTCAACTGTGATGTTTTGTCTTACTTCCCAAACCTCCTGACGCA TCCAAAAGAGAAGATAAACAAGGAAGCAGTTTGGTTCCTTTCCAATATCACAGCAGGAAACCAGCAAC AAGTTCAGGCTGTAATAGATGCTGGGCTAATCCCTATGATCATACACCAGCTGGCTAAGGGTGACTTT GGAACACAGAAGGAAGCTGCTTGGGCAATTAGCAATTTGACAATAAGTGGGAGAAAAGATCAGGTTGA ATACCTTGTACAGCAAAACGTAATCCCACCATTCTGCAATCTACTCTCAGTAAAGGATTCTCAAGTGG TGCAGGTGGTGCTGGATGGTCTGAAAAACATCCTGATAATGGCTGGTGATGAGGCTAGCACAATAGCT GAAATTATAGAAGAGTGTGGAGGGTTAGAGAAAATTGAAGCCTTGCAACAACATGAGAATGAAGACAT TTATAAACTAGCGTTTGAAATCATAGATCAATATTTCTCTGGTGATGATATCGATGAGGATCCCAGTC TCATTCCTGAAGCCACTCAAGGAGGTACTTACAATTTTGACCCGACAGCCAACCTTCAAACAAAAGAA TTTAATTTTTAA
SEQ ID NO.4
chicken KPNA4 gene sequence:
ATGGCCGACAACGAGAAACTGGACAACCAGCGGCTGAAGAACTTCAAGAACAAAGGCCGCGACC TGGAGACTATGAGAAGACAAAGGAATGAAGTTGTCGTGGAGTTGAGAAAGAACAAAAGAGACGAACAT CTTCTAAAGAGGAGGAATGTACCCCATGAGGATATCTGTGAAGATTCCGACGTAGATGGTGACTTCAG AGTGCAAAACACTTCTTTGGAAGCAATAGTACAGAATGCTTCAAGTGACAACCAGGGTATACAGTTAA GTGCTGTGCAAGCTGCAAGAAAACTGCTTTCCAGTGATCGCAATCCACCAATTGATGATCTAATAAAA TCAGGAATATTACCTATTCTAGTGCACTGTCTTGAAAGAGATGACAATCCTTCTTTACAGTTTGAAGC TGCATGGGCTTTGACAAACATTGCATCTGGAACCTCTGAACAAACACAGGCCGTGGTTCAATCTAATG CTGTACCACTTTTTCTGAGACTGCTGCATTCACCTCACCAAAATGTTTGTGAACAAGCTGTGTGGGCT TTAGGCAATATCATAGGTGATGGACCCCAGTGTAGAGATTACGTTATTAGTCTTGGAGTAGTGAAACC ACTGCTGTCCTTCATCAGCCCATCTATTCCCATAACTTTCTTAAGAAACGTTACTTGGGTCATGGTCA ACTTGTGCCGTCACAAAGATCCTCCTCCGCCCATGGAAACCATTCAGGAGATCCTTCCAGCCCTCTGT GTTTTAATTCACCACACAGATGTAAATATATTGGTAGATACAGTCTGGGCACTCTCATATCTAACGGA TGCTGGCAATGAACAGATCCAGATGGTGATAGACTCCGGAATAGTCCCTCATTTGGTTCCTCTTCTCA GTCATCAAGAAGTGAAAGTGCAGACTGCTGCGCTGAGAGCGGTAGGAAACATTGTCACTGGTACCGAT GAGCAGACACAGGTAGTTCTGAATTGTGAAGCTCTTTCACATTTCCCAGCACTTCTGACACATCCCAA AGAAAAAATTAATAAGGAAGCAGTGTGGTTTCTATCTAACATCACTGCAGGAAATCAGCAGCAAGTTC AGGCAGTAATAGATGCAAACCTTGTTCCAATGATAATACATCTTCTAGATAAGGGTGACTTTGGTACT CAGAAAGAAGCTGCTTGGGCAATAAGCAATTTAACAATCAGCGGAAGAAAAGACCAAGTGGCATACTT AATTCAACAAAACGTAATTCCTCCCTTTTGCAATTTGCTAACAGTAAAAGATGCACAAGTTGTGCAAG TGGTTCTGGATGGACTAAGTAATATATTAAAAATGGCTGAAGATGAAGCAGAAACCATAGCCAATCTT ATTGAAGAGTGCGGAGGCCTGGAGAAAATTGAACAGCTACAAAACCATGAAAATGAAGACATCTACAA ACTGGCTTATGAGATCATTGATCAGTTCTTCTCTTCAGATGATATTGATGAAGATCCTAGCCTTGTAC CGGAAGCAATACAAGGCGGAACATTTGGTTTCAATTCATCTGCCAATGTACCAGCAGAAGGGTTCCAG TTTTAG
SEQ ID NO.9
sequence of donor plasmid HR1-EGFP-F2 ═ HR 2:
GGTGACCTACTGACCCTCAACACCAAAACGCCCATTTACGTCAGCGATCGAGCGGTCAGTCTGC TCATCGATGACAATACTTTGGCCACTAAGCAAGCCAACGGGGCGCTCATGGTCAAAACCGCGGCCCCT CTGAACTCGGGCACTGGTGGAGGCGTCACGCTAGGCTTCGACCCTCGCACCATGGCGCTAGATTCCGT CACCGGGGTGCTCAAAGTGCTCGTCGACTCACAGGGACCTCTACAAGCCGACACGGGAGGCATCACTC TCCAGTTCGACACTCAAGACTTCGTTGTCAACAATGGCGTCTTAGCGCTAGCCTCCTCGGTCGGTCCG ACCTATCTGAGCCCCTTTGCGACCTACGAAGTCACGCCCGTCTTGGGAATATCGCAGAGGAACGGCAA CGTAAAAAGCAAGGGCTTGCAAAACTGGTCCATAGGCTATTACATCTACATGGTGAGCTCAGCCGGGC TAGTCAACGGACTCATCACTCTGGAGCTAGCCCATGACCTCACAGGCGCGAGCGGAGAAAACAGCCTG ACTAGCGGTCTCAACTTTACCTTTGTGCTCAGCCCCATGTACCCGATAGAAACAGAGGTGAATTTGTC CCTCATCGTGCCGCCCACGGTCTCGCCGACCAATCAAAACCACGTGTTTGTGCCCAATAGCAACCAGA GCGACGTGGGCTATCTCGGGCTGCCGCCTCATACCAGGGACAATTGGTACGTGCCCATCGACTCGCCC GGCCTGCGGCTCGTCTCTTTCATGCCCACCGCCACCGGAAACGAGAAATTCGGACAGGGCACGTTGGG ATACTGCGCCGCCACCATCCAGAACACGTCCAGCGGAACCACGCCGTCGGATGCGATAGCCTTCACTG TCTCGCTGCCGCAGACCTCCGGCTCCAACTGGTTTGACCAGAACGCGCCCGACACTGTGGTGACGACC GGTCCTATCCCTTTTTCCTATCAGGGTTACGTCTACTCCCCCAACGGGAACAATGGTGAGCAAGGGCG AGGAGCTGTTCACCGGGGTGGTGCCCATCCTGGTCGAGCTGGACGGCGACGTAAACGGCCACAAGTTC AGCGTGTCCGGCGAGGGCGAGGGCGATGCCACCTACGGCAAGCTGACCCTGAAGTTCATCTGCACCAC CGGCAAGCTGCCCGTGCCCTGGCCCACCCTCGTGACCACCCTGACCTACGGCGTGCAGTGCTTCAGCC GCTACCCCGACCACATGAAGCAGCACGACTTCTTCAAGTCCGCCATGCCCGAAGGCTACGTCCAGGAG CGCACCATCTTCTTCAAGGACGACGGCAACTACAAGACCCGCGCCGAGGTGAAGTTCGAGGGCGACAC CCTGGTGAACCGCATCGAGCTGAAGGGCATCGACTTCAAGGAGGACGGCAACATCCTGGGGCACAAGC TGGAGTACAACTACAACAGCCACAACGTCTATATCATGGCCGACAAGCAGAAGAACGGCATCAAGGTG AACTTCAAGATCCGCCACAACATCGAGGACGGCAGCGTGCAGCTCGCCGACCACTACCAGCAGAACAC CCCCATCGGCGACGGCCCCGTGCTGCTGCCCGACAACCACTACCTGAGCACCCAGTCCGCCCTGAGCA AAGACCCCAACGAGAAGCGCGATCACATGGTCCTGCTGGAGTTCGTGACCGCCGCCGGGATCACTCTC GGCATGGACGAGCTGTACAAGCTCCGGGCCCCTAAAAGAAGACATTCCGAAAACGGGAAGCCCGAGAC CGAAGCGGGACCTTCCCCGGCTCCAATCAAGCGCGCCAAACGCATGGTGAGAGCATCCCAGCTTGACC TGGTTTATCCTTTCGATTACGTGGCCGACCCCGTCGGAGGGCTCAACCCGCCTTTTTTGGGAGGCTCA GGACCCCTAGTGGACCAGGGCGGACAGCTTACGCTCAACGTCACCGATCCCATCATCATCAAGAACAG ATCGGTGGACTTGGCCCACGACCCCAGTCTCGATGTCAACGCCCAAGGTCAACTGGCGGTGGCCGTTG ACCCCGAAGGGGCCCTGGACATCACCCCCGATGGACTGGACGTCAAGGTCGACGGAGTGACCGTAATG GTCAACGATGACTGGGAACTGGCCGTAAAAGTCGACCCGTCCGGCGGATTGGATtCCACCGCGGGTGG ACTGGGGGTCAGCGTGGACGACACCTTGCTCGTGGATCAGGGAGAACTGGGCGTACACCTCAACCAAC AAGGACCCATCACTGCCGATAGCAGTGGTATCGACCTCGAGATCAATCCTAACATGTTCACGGTCAAC ACCTCGACCGGAAGCGGAGTGCTGGAACTCAACCTAAAAGCGCAGGGAGGCATCCAAGCCGACAGTTC GGGAGTGGGCGTTTCCGTGGATGAAAGCCTACAGATTGTCAACAACACTCTGGAAGTGAAACCGGATC CCAGCGGACCGCTTACGGTCTCCGCCAATGGCCTAGGGCTGAAGTACGACACTAATACCCTAGCGGTG ACCGCGGGCGCTTTAACCGTGGTCGGAGGGGGGAGCGTCTCCACACCCATCGCTACTTTTGTCTCGGG AAGTCCCAGCCTCAACACCTACAATGCCACGACCGTCAATTCCAGCGCGAACGCCTTCTCTTGCGCCT ACTACCTTCAACAGTGGAACATACAGGGGCTCCTTGTTACCTCCCTCTACTTGAAATTGGACAGCGCC ACCATGGGGAATCGCCCTGGGGACCTCAACTCCGCCAATGCCAAATGGTTCACCTTTTGGGTGTCCGC CTATCTCCAGCAATGCAACCCCTCCGGGATTCAAGCGGGAACGGTCAGCCCCTCCACCGCCACCCTCA CGGACTTTGAACCCATGGCCAATAGGAGCGTGACCAGCCCATGGACGTACTCGGCCAATGGATACTAT GAACCATCCATCGGGGAATTCCAAGTGTTCAGCCCGGTGGTAACAGGTGCCTGGAACCCGGGAAACAT AGGGATCCGCGTCCTCCCCGTGCCGGTTTCGGCCTCCGGAGAGCGATACACCCTTCTATGCTATAGTC TGCAGTGCACGAACGCGAGCATTTTTAATCCAAACAACAGCGGAACCATGATCGTGGGACCCGTGCTC TACAGCTGTCCAGCGGCCTCCCTCCCGTAAGCGCGCCCTCCCCACCGCGTGTCAAATAAAGAGTCATG AACGTTGATTGCTTTTATTGATCGTCCATTTGTCCGAAAGCTTCTCTCCTTTGTTCCCGCGTCCAATC ATACAACAGATTTACGCTTTCTAAAAACCAATCGGGTGCGTAAAAGCGAGTAATGTTGTGTTCCACAC TGATTTCCATTTTGCGCAAGTAGTGACAGGGGAGCGCCCCCAAGGCTCCAAGCTGGGATACTACCATC AGGAATTCGGCCCGTCTGTCGATAGGGTAAAGAGGTACATGAATCATCATGCCCACCACGCCCTGCAG GTGGTGGACTACCATGGGTCCAAAGGAGGAAAACATGGCACACGCCCACGCGCACACAAAATAGTTCC CGGCTACCCCGTAGTCCTCCGAAAGTCCCTCGCACAGCTTATCCCCGTACCTACAGTACACCCCGGTT CCCACAGACAACCCCAAATTGCGCAAACCGTAATTGTGACACACACAGTTTTTGACCACCACCCTCAT TCTCTCCATGCAAGCAAGCACCATGTTTTCATGCGGATTGGCTGCGGCCTCCGCCGCTGCGAGCTCCT CCTCCTCTTCGGCAAGGGGGGCCTCCTCCATCGGTTCGGGTGATGCGTCACGCTCCTCCATCTCTAAA CCTGGGTCTCGTAGGGCGAAATGGAAGTGTACACGTGATCGTAAGGGTCCTCGAGTTCAGAGTATGGG TTGACAGGCACAGGCGGCAGCGGTCGCGACGCGCCTAACCCGATGCGCAAACTAGAGTACAGCGGATT GGCTGACAGTACCCACCTACCCGATCCCCGCCTTCTGAGGGACCGGACCTCTGGGGGCGTGCAACGGG GCCGTCGGAACCTCACAAGTCCACTCCCTGATAATAAAGTACAGCACAATCAACACCATTAAACTGCT GGTGAGAAACACGGTTATGACATAGAGCAACAGACTGACGGAGCGTTCCACGAAAAGAAAACTGACGA AATGCAGGTAAAGTAG。
sequence listing
<110> Yangzhou university
<120> F2 partial deletion type recombinant serum type 4 avian adenovirus and preparation method thereof
<160> 17
<170> SIPOSequenceListing 1.0
<210> 1
<211> 1440
<212> DNA
<213> Victoria jellyfish (Aequorea victoria)
<400> 1
atgctccggg cccctaaaag aagacattcc gaaaacggga agcccgagac cgaagcggga 60
ccttccccgg ctccaatcaa gcgcgccaaa cgcatggtga gagcatccca gcttgacctg 120
gtttatcctt tcgattacgt ggccgacccc gtcggagggc tcaacccgcc ttttttggga 180
ggctcaggac ccctagtgga ccagggcgga cagcttacgc tcaacgtcac cgatcccatc 240
atcatcaaga acagatcggt ggacttggcc cacgacccca gtctcgatgt caacgcccaa 300
ggtcaactgg cggtggccgt tgaccccgaa ggggccctgg acatcacccc cgatggactg 360
gacgtcaagg tcgacggagt gaccgtaatg gtcaacgatg actgggaact ggccgtaaaa 420
gtcgacccgt ccggcggatt ggattccacc gcgggtggac tgggggtcag cgtggacgac 480
accttgctcg tggatcaggg agaactgggc gtacacctca accaacaagg acccatcact 540
gccgatagca gtggtatcga cctcgagatc aatcctaaca tgttcacggt caacacctcg 600
accggaagcg gagtgctgga actcaaccta aaagcgcagg gaggcatcca agccgacagt 660
tcgggagtgg gcgtttccgt ggatgaaagc ctacagattg tcaacaacac tctggaagtg 720
aaaccggatc ccagcggacc gcttacggtc tccgccaatg gcctagggct gaagtacgac 780
actaataccc tagcggtgac cgcgggcgct ttaaccgtgg tcggaggggg gagcgtctcc 840
acacccatcg ctacttttgt ctcgggaagt cccagcctca acacctacaa tgccacgacc 900
gtcaattcca gcgcgaacgc cttctcttgc gcctactacc ttcaacagtg gaacatacag 960
gggctccttg ttacctccct ctacttgaaa ttggacagcg ccaccatggg gaatcgccct 1020
ggggacctca actccgccaa tgccaaatgg ttcacctttt gggtgtccgc ctatctccag 1080
caatgcaacc cctccgggat tcaagcggga acggtcagcc cctccaccgc caccctcacg 1140
gactttgaac ccatggccaa taggagcgtg accagcccat ggacgtactc ggccaatgga 1200
tactatgaac catccatcgg ggaattccaa gtgttcagcc cggtggtaac aggtgcctgg 1260
aacccgggaa acatagggat ccgcgtcctc cccgtgccgg tttcggcctc cggagagcga 1320
tacacccttc tatgctatag tctgcagtgc acgaacgcga gcatttttaa tccaaacaac 1380
agcggaacca tgatcgtggg acccgtgctc tacagctgtc cagcggcctc cctcccgtaa 1440
<210> 2
<211> 1338
<212> DNA
<213> Chicken (Chicken)
<400> 2
atgctccggg cccctaaagt ttatcctttc gattacgtgg ccgaccccgt cggagggctc 60
aacccgcctt ttttgggagg ctcaggaccc ctagtggacc agggcggaca gcttacgctc 120
aacgtcaccg atcccatcat catcaagaac agatcggtgg acttggccca cgaccccagt 180
ctcgatgtca acgcccaagg tcaactggcg gtggccgttg accccgaagg ggccctggac 240
atcacccccg atggactgga cgtcaaggtc gacggagtga ccgtaatggt caacgatgac 300
tgggaactgg ccgtaaaagt cgacccgtcc ggcggattgg attccaccgc gggtggactg 360
ggggtcagcg tggacgacac cttgctcgtg gatcagggag aactgggcgt acacctcaac 420
caacaaggac ccatcactgc cgatagcagt ggtatcgacc tcgagatcaa tcctaacatg 480
ttcacggtca acacctcgac cggaagcgga gtgctggaac tcaacctaaa agcgcaggga 540
ggcatccaag ccgacagttc gggagtgggc gtttccgtgg atgaaagcct acagattgtc 600
aacaacactc tggaagtgaa accggatccc agcggaccgc ttacggtctc cgccaatggc 660
ctagggctga agtacgacac taatacccta gcggtgaccg cgggcgcttt aaccgtggtc 720
ggagggggga gcgtctccac acccatcgct acttttgtct cgggaagtcc cagcctcaac 780
acctacaatg ccacgaccgt caattccagc gcgaacgcct tctcttgcgc ctactacctt 840
caacagtgga acatacaggg gctccttgtt acctccctct acttgaaatt ggacagcgcc 900
accatgggga atcgccctgg ggacctcaac tccgccaatg ccaaatggtt caccttttgg 960
gtgtccgcct atctccagca atgcaacccc tccgggattc aagcgggaac ggtcagcccc 1020
tccaccgcca ccctcacgga ctttgaaccc atggccaata ggagcgtgac cagcccatgg 1080
acgtactcgg ccaatggata ctatgaacca tccatcgggg aattccaagt gttcagcccg 1140
gtggtaacag gtgcctggaa cccgggaaac atagggatcc gcgtcctccc cgtgccggtt 1200
tcggcctccg gagagcgata cacccttcta tgctatagtc tgcagtgcac gaacgcgagc 1260
atttttaatc caaacaacag cggaaccatg atcgtgggac ccgtgctcta cagctgtcca 1320
gcggcctccc tcccgtaa 1338
<210> 3
<211> 1572
<212> DNA
<213> Chicken (Chicken)
<400> 3
atggccgaga acgccgccgc cggcctggag aaccaccgca tcaagagctt caagaacaag 60
ggccgcgacg tggagactat gaggagacac agaaacgaag ttacaattga attgaggaag 120
aacaaaagag atgaacatct tttgaaaaaa cgaaacgttc cccaagaaga aagtttagaa 180
gattctgatg ttgatgctga cttcaaagca caaaacgtaa cactagaagc tatactgcag 240
aacgccacaa gtgacaaccc agtgatccaa ctgagtgctg ttcaagctgc aagaaaactc 300
ctatccagtg acagaaatcc acctattgat gacttaataa aatctggaat tttgccaatt 360
ctggtaaaat gcctagaaag ggatgataat ccttcattac aatttgaagc tgcatgggca 420
ttgactaaca tagcatcagg cacttctgca caaactcaag ctgttgtaca gtctaatgca 480
gtacccctct ttttgagact actccattct ccgcaccaga acgtttgtga gcaggctgtg 540
tgggccctcg gaaatatcat tggtgatggt cctcagtgta gagattatgt catatcactg 600
ggagttgtca aacctcttct gtccttcatc aatccctcca ttcccatcac cttccttcgg 660
aacgtcacat gggtcattgt aaatctctgc aggaataagg accccccacc gcctatggag 720
acagttcagg agattttgcc agcattgtgt gttctcattt accatacaga tataaacatt 780
ctcgtggaca ccgtttgggc tttgtcctac ttaacagacg gtggcaacga gcagatacag 840
atggtgattg attcgggagt tgtacctttt ctagttcccc ttctgagtca ccaggaggtc 900
aaagttcaga cagcagcact gagagcagta ggcaacatag taaccggtac cgatgaacag 960
acacaagttg ttctcaactg tgatgttttg tcttacttcc caaacctcct gacgcatcca 1020
aaagagaaga taaacaagga agcagtttgg ttcctttcca atatcacagc aggaaaccag 1080
caacaagttc aggctgtaat agatgctggg ctaatcccta tgatcataca ccagctggct 1140
aagggtgact ttggaacaca gaaggaagct gcttgggcaa ttagcaattt gacaataagt 1200
gggagaaaag atcaggttga ataccttgta cagcaaaacg taatcccacc attctgcaat 1260
ctactctcag taaaggattc tcaagtggtg caggtggtgc tggatggtct gaaaaacatc 1320
ctgataatgg ctggtgatga ggctagcaca atagctgaaa ttatagaaga gtgtggaggg 1380
ttagagaaaa ttgaagcctt gcaacaacat gagaatgaag acatttataa actagcgttt 1440
gaaatcatag atcaatattt ctctggtgat gatatcgatg aggatcccag tctcattcct 1500
gaagccactc aaggaggtac ttacaatttt gacccgacag ccaaccttca aacaaaagaa 1560
tttaattttt aa 1572
<210> 4
<211> 1566
<212> DNA
<213> Chicken (Chicken)
<400> 4
atggccgaca acgagaaact ggacaaccag cggctgaaga acttcaagaa caaaggccgc 60
gacctggaga ctatgagaag acaaaggaat gaagttgtcg tggagttgag aaagaacaaa 120
agagacgaac atcttctaaa gaggaggaat gtaccccatg aggatatctg tgaagattcc 180
gacgtagatg gtgacttcag agtgcaaaac acttctttgg aagcaatagt acagaatgct 240
tcaagtgaca accagggtat acagttaagt gctgtgcaag ctgcaagaaa actgctttcc 300
agtgatcgca atccaccaat tgatgatcta ataaaatcag gaatattacc tattctagtg 360
cactgtcttg aaagagatga caatccttct ttacagtttg aagctgcatg ggctttgaca 420
aacattgcat ctggaacctc tgaacaaaca caggccgtgg ttcaatctaa tgctgtacca 480
ctttttctga gactgctgca ttcacctcac caaaatgttt gtgaacaagc tgtgtgggct 540
ttaggcaata tcataggtga tggaccccag tgtagagatt acgttattag tcttggagta 600
gtgaaaccac tgctgtcctt catcagccca tctattccca taactttctt aagaaacgtt 660
acttgggtca tggtcaactt gtgccgtcac aaagatcctc ctccgcccat ggaaaccatt 720
caggagatcc ttccagccct ctgtgtttta attcaccaca cagatgtaaa tatattggta 780
gatacagtct gggcactctc atatctaacg gatgctggca atgaacagat ccagatggtg 840
atagactccg gaatagtccc tcatttggtt cctcttctca gtcatcaaga agtgaaagtg 900
cagactgctg cgctgagagc ggtaggaaac attgtcactg gtaccgatga gcagacacag 960
gtagttctga attgtgaagc tctttcacat ttcccagcac ttctgacaca tcccaaagaa 1020
aaaattaata aggaagcagt gtggtttcta tctaacatca ctgcaggaaa tcagcagcaa 1080
gttcaggcag taatagatgc aaaccttgtt ccaatgataa tacatcttct agataagggt 1140
gactttggta ctcagaaaga agctgcttgg gcaataagca atttaacaat cagcggaaga 1200
aaagaccaag tggcatactt aattcaacaa aacgtaattc ctcccttttg caatttgcta 1260
acagtaaaag atgcacaagt tgtgcaagtg gttctggatg gactaagtaa tatattaaaa 1320
atggctgaag atgaagcaga aaccatagcc aatcttattg aagagtgcgg aggcctggag 1380
aaaattgaac agctacaaaa ccatgaaaat gaagacatct acaaactggc ttatgagatc 1440
attgatcagt tcttctcttc agatgatatt gatgaagatc ctagccttgt accggaagca 1500
atacaaggcg gaacatttgg tttcaattca tctgccaatg taccagcaga agggttccag 1560
ttttag 1566
<210> 5
<211> 25
<212> DNA
<213> Artificial Sequence (Artificial Sequence)
<400> 5
caccgtccta tccctttttc ctatc 25
<210> 6
<211> 25
<212> DNA
<213> Artificial Sequence (Artificial Sequence)
<400> 6
aaacgatagg aaaaagggat aggac 25
<210> 7
<211> 25
<212> DNA
<213> Artificial Sequence (Artificial Sequence)
<400> 7
caccggctta cgggagggag gccgc 25
<210> 8
<211> 25
<212> DNA
<213> Artificial Sequence (Artificial Sequence)
<400> 8
aaacgcggcc tccctcccgt aagcc 25
<210> 9
<211> 25
<212> DNA
<213> Artificial Sequence (Artificial Sequence)
<400> 9
caccgatggc cgagaacgcc gccgc 25
<210> 10
<211> 25
<212> DNA
<213> Artificial Sequence (Artificial Sequence)
<400> 10
aaacgcggcg gcgttctcgg ccatc 25
<210> 11
<211> 25
<212> DNA
<213> Artificial Sequence (Artificial Sequence)
<400> 11
caccggttgt ccagtttctc gttgt 25
<210> 12
<211> 25
<212> DNA
<213> Artificial Sequence (Artificial Sequence)
<400> 12
aaacacaacg agaaactgga caacc 25
<210> 13
<211> 41
<212> DNA
<213> Artificial Sequence (Artificial Sequence)
<400> 13
caatgctccg ggcccctaaa gtttatcctt tcgattacgt g 41
<210> 14
<211> 42
<212> DNA
<213> Artificial Sequence (Artificial Sequence)
<400> 14
ctttaggggc ccggagcatt gttcccgttg ggggagtaga cg 42
<210> 15
<211> 23
<212> DNA
<213> Artificial Sequence (Artificial Sequence)
<400> 15
ctccaactgg tttgaccaga acg 23
<210> 16
<211> 28
<212> DNA
<213> Artificial Sequence (Artificial Sequence)
<400> 16
cgttcatgac tctttatttg acacgcgg 28
<210> 17
<211> 4160
<212> DNA
<213> Artificial Sequence (Artificial Sequence)
<400> 17
ggtgacctac tgaccctcaa caccaaaacg cccatttacg tcagcgatcg agcggtcagt 60
ctgctcatcg atgacaatac tttggccact aagcaagcca acggggcgct catggtcaaa 120
accgcggccc ctctgaactc gggcactggt ggaggcgtca cgctaggctt cgaccctcgc 180
accatggcgc tagattccgt caccggggtg ctcaaagtgc tcgtcgactc acagggacct 240
ctacaagccg acacgggagg catcactctc cagttcgaca ctcaagactt cgttgtcaac 300
aatggcgtct tagcgctagc ctcctcggtc ggtccgacct atctgagccc ctttgcgacc 360
tacgaagtca cgcccgtctt gggaatatcg cagaggaacg gcaacgtaaa aagcaagggc 420
ttgcaaaact ggtccatagg ctattacatc tacatggtga gctcagccgg gctagtcaac 480
ggactcatca ctctggagct agcccatgac ctcacaggcg cgagcggaga aaacagcctg 540
actagcggtc tcaactttac ctttgtgctc agccccatgt acccgataga aacagaggtg 600
aatttgtccc tcatcgtgcc gcccacggtc tcgccgacca atcaaaacca cgtgtttgtg 660
cccaatagca accagagcga cgtgggctat ctcgggctgc cgcctcatac cagggacaat 720
tggtacgtgc ccatcgactc gcccggcctg cggctcgtct ctttcatgcc caccgccacc 780
ggaaacgaga aattcggaca gggcacgttg ggatactgcg ccgccaccat ccagaacacg 840
tccagcggaa ccacgccgtc ggatgcgata gccttcactg tctcgctgcc gcagacctcc 900
ggctccaact ggtttgacca gaacgcgccc gacactgtgg tgacgaccgg tcctatccct 960
ttttcctatc agggttacgt ctactccccc aacgggaaca atggtgagca agggcgagga 1020
gctgttcacc ggggtggtgc ccatcctggt cgagctggac ggcgacgtaa acggccacaa 1080
gttcagcgtg tccggcgagg gcgagggcga tgccacctac ggcaagctga ccctgaagtt 1140
catctgcacc accggcaagc tgcccgtgcc ctggcccacc ctcgtgacca ccctgaccta 1200
cggcgtgcag tgcttcagcc gctaccccga ccacatgaag cagcacgact tcttcaagtc 1260
cgccatgccc gaaggctacg tccaggagcg caccatcttc ttcaaggacg acggcaacta 1320
caagacccgc gccgaggtga agttcgaggg cgacaccctg gtgaaccgca tcgagctgaa 1380
gggcatcgac ttcaaggagg acggcaacat cctggggcac aagctggagt acaactacaa 1440
cagccacaac gtctatatca tggccgacaa gcagaagaac ggcatcaagg tgaacttcaa 1500
gatccgccac aacatcgagg acggcagcgt gcagctcgcc gaccactacc agcagaacac 1560
ccccatcggc gacggccccg tgctgctgcc cgacaaccac tacctgagca cccagtccgc 1620
cctgagcaaa gaccccaacg agaagcgcga tcacatggtc ctgctggagt tcgtgaccgc 1680
cgccgggatc actctcggca tggacgagct gtacaagctc cgggccccta aaagaagaca 1740
ttccgaaaac gggaagcccg agaccgaagc gggaccttcc ccggctccaa tcaagcgcgc 1800
caaacgcatg gtgagagcat cccagcttga cctggtttat cctttcgatt acgtggccga 1860
ccccgtcgga gggctcaacc cgcctttttt gggaggctca ggacccctag tggaccaggg 1920
cggacagctt acgctcaacg tcaccgatcc catcatcatc aagaacagat cggtggactt 1980
ggcccacgac cccagtctcg atgtcaacgc ccaaggtcaa ctggcggtgg ccgttgaccc 2040
cgaaggggcc ctggacatca cccccgatgg actggacgtc aaggtcgacg gagtgaccgt 2100
aatggtcaac gatgactggg aactggccgt aaaagtcgac ccgtccggcg gattggattc 2160
caccgcgggt ggactggggg tcagcgtgga cgacaccttg ctcgtggatc agggagaact 2220
gggcgtacac ctcaaccaac aaggacccat cactgccgat agcagtggta tcgacctcga 2280
gatcaatcct aacatgttca cggtcaacac ctcgaccgga agcggagtgc tggaactcaa 2340
cctaaaagcg cagggaggca tccaagccga cagttcggga gtgggcgttt ccgtggatga 2400
aagcctacag attgtcaaca acactctgga agtgaaaccg gatcccagcg gaccgcttac 2460
ggtctccgcc aatggcctag ggctgaagta cgacactaat accctagcgg tgaccgcggg 2520
cgctttaacc gtggtcggag gggggagcgt ctccacaccc atcgctactt ttgtctcggg 2580
aagtcccagc ctcaacacct acaatgccac gaccgtcaat tccagcgcga acgccttctc 2640
ttgcgcctac taccttcaac agtggaacat acaggggctc cttgttacct ccctctactt 2700
gaaattggac agcgccacca tggggaatcg ccctggggac ctcaactccg ccaatgccaa 2760
atggttcacc ttttgggtgt ccgcctatct ccagcaatgc aacccctccg ggattcaagc 2820
gggaacggtc agcccctcca ccgccaccct cacggacttt gaacccatgg ccaataggag 2880
cgtgaccagc ccatggacgt actcggccaa tggatactat gaaccatcca tcggggaatt 2940
ccaagtgttc agcccggtgg taacaggtgc ctggaacccg ggaaacatag ggatccgcgt 3000
cctccccgtg ccggtttcgg cctccggaga gcgatacacc cttctatgct atagtctgca 3060
gtgcacgaac gcgagcattt ttaatccaaa caacagcgga accatgatcg tgggacccgt 3120
gctctacagc tgtccagcgg cctccctccc gtaagcgcgc cctccccacc gcgtgtcaaa 3180
taaagagtca tgaacgttga ttgcttttat tgatcgtcca tttgtccgaa agcttctctc 3240
ctttgttccc gcgtccaatc atacaacaga tttacgcttt ctaaaaacca atcgggtgcg 3300
taaaagcgag taatgttgtg ttccacactg atttccattt tgcgcaagta gtgacagggg 3360
agcgccccca aggctccaag ctgggatact accatcagga attcggcccg tctgtcgata 3420
gggtaaagag gtacatgaat catcatgccc accacgccct gcaggtggtg gactaccatg 3480
ggtccaaagg aggaaaacat ggcacacgcc cacgcgcaca caaaatagtt cccggctacc 3540
ccgtagtcct ccgaaagtcc ctcgcacagc ttatccccgt acctacagta caccccggtt 3600
cccacagaca accccaaatt gcgcaaaccg taattgtgac acacacagtt tttgaccacc 3660
accctcattc tctccatgca agcaagcacc atgttttcat gcggattggc tgcggcctcc 3720
gccgctgcga gctcctcctc ctcttcggca aggggggcct cctccatcgg ttcgggtgat 3780
gcgtcacgct cctccatctc taaacctggg tctcgtaggg cgaaatggaa gtgtacacgt 3840
gatcgtaagg gtcctcgagt tcagagtatg ggttgacagg cacaggcggc agcggtcgcg 3900
acgcgcctaa cccgatgcgc aaactagagt acagcggatt ggctgacagt acccacctac 3960
ccgatccccg ccttctgagg gaccggacct ctgggggcgt gcaacggggc cgtcggaacc 4020
tcacaagtcc actccctgat aataaagtac agcacaatca acaccattaa actgctggtg 4080
agaaacacgg ttatgacata gagcaacaga ctgacggagc gttccacgaa aagaaaactg 4140
acgaaatgca ggtaaagtag 4160

Claims (5)

1. An F2 partial deletion type recombinant avian adenovirus serotype 4 is characterized in that the carrier framework is a wild avian adenovirus serotype 4 SD strain;
the F2 partially-deleted recombinant serotype 4 avian adenovirus is obtained by editing an F2 gene through a CRISPR-Cas9 technology on the basis of an FAdV4-EGFP recombinant virus, wherein the sequence of the full-length F2 gene is shown as SEQ ID No. 1;
SEQ ID NO.1 is:
ATGCTCCGGGCCCCTAAAAGAAGACATTCCGAAAACGGGAAGCCCGAGACCGAAGCGGGACCTTCCCCGGCTCCAATCAAGCGCGCCAAACGCATGGTGAGAGCATCCCAGCTTGACCTGGTTTATCCTTTCGATTACGTGGCCGACCCCGTCGGAGGGCTCAACCCGCCTTTTTTGGGAGGCTCAGGACCCCTAGTGGACCAGGGCGGACAGCTTACGCTCAACGTCACCGATCCCATCATCATCAAGAACAGATCGGTGGACTTGGCCCACGACCCCAGTCTCGATGTCAACGCCCAAGGTCAACTGGCGGTGGCCGTTGACCCCGAAGGGGCCCTGGACATCACCCCCGATGGACTGGACGTCAAGGTCGACGGAGTGACCGTAATGGTCAACGATGACTGGGAACTGGCCGTAAAAGTCGACCCGTCCGGCGGATTGGATtCCACCGCGGGTGGACTGGGGGTCAGCGTGGACGACACCTTGCTCGTGGATCAGGGAGAACTGGGCGTACACCTCAACCAACAAGGACCCATCACTGCCGATAGCAGTGGTATCGACCTCGAGATCAATCCTAACATGTTCACGGTCAACACCTCGACCGGAAGCGGAGTGCTGGAACTCAACCTAAAAGCGCAGGGAGGCATCCAAGCCGACAGTTCGGGAGTGGGCGTTTCCGTGGATGAAAGCCTACAGATTGTCAACAACACTCTGGAAGTGAAACCGGATCCCAGCGGACCGCTTACGGTCTCCGCCAATGGCCTAGGGCTGAAGTACGACACTAATACCCTAGCGGTGACCGCGGGCGCTTTAACCGTGGTCGGAGGGGGGAGCGTCTCCACACCCATCGCTACTTTTGTCTCGGGAAGTCCCAGCCTCAACACCTACAATGCCACGACCGTCAATTCCAGCGCGAACGCCTTCTCTTGCGCCTACTACCTTCAACAGTGGAACATACAGGGGCTCCTTGTTACCTCCCTCTACTTGAAATTGGACAGCGCCACCATGGGGAATCGCCCTGGGGACCTCAACTCCGCCAATGCCAAATGGTTCACCTTTTGGGTGTCCGCCTATCTCCAGCAATGCAACCCCTCCGGGATTCAAGCGGGAACGGTCAGCCCCTCCACCGCCACCCTCACGGACTTTGAACCCATGGCCAATAGGAGCGTGACCAGCCCATGGACGTACTCGGCCAATGGATACTATGAACCATCCATCGGGGAATTCCAAGTGTTCAGCCCGGTGGTAACAGGTGCCTGGAACCCGGGAAACATAGGGATCCGCGTCCTCCCCGTGCCGGTTTCGGCCTCCGGAGAGCGATACACCCTTCTATGCTATAGTCTGCAGTGCACGAACGCGAGCATTTTTAATCCAAACAACAGCGGAACCATGATCGTGGGACCCGTGCTCTACAGCTGTCCAGCGGCCTCCCTCCCGTAA。
2. the partially F2-deleted recombinant serotype 4 avian adenovirus according to claim 1,
the partial gene of the deletion F2 is characterized in that the amino acids at positions 7-40 of F2 are identified as functional regions interacting with host protein by silver staining, mass spectrometry and co-immunoprecipitation technology, and the sequence of the partial gene of the deletion F2 is shown as SEQ ID NO. 2;
SEQ ID NO.2 is:
ATGCTCCGGGCCCCTAAAGTTTATCCTTTCGATTACGTGGCCGACCCCGTCGGAGGGCTCAACCCGCCTTTTTTGGGAGGCTCAGGACCCCTAGTGGACCAGGGCGGACAGCTTACGCTCAACGTCACCGATCCCATCATCATCAAGAACAGATCGGTGGACTTGGCCCACGACCCCAGTCTCGATGTCAACGCCCAAGGTCAACTGGCGGTGGCCGTTGACCCCGAAGGGGCCCTGGACATCACCCCCGATGGACTGGACGTCAAGGTCGACGGAGTGACCGTAATGGTCAACGATGACTGGGAACTGGCCGTAAAAGTCGACCCGTCCGGCGGATTGGATtCCACCGCGGGTGGACTGGGGGTCAGCGTGGACGACACCTTGCTCGTGGATCAGGGAGAACTGGGCGTACACCTCAACCAACAAGGACCCATCACTGCCGATAGCAGTGGTATCGACCTCGAGATCAATCCTAACATGTTCACGGTCAACACCTCGACCGGAAGCGGAGTGCTGGAACTCAACCTAAAAGCGCAGGGAGGCATCCAAGCCGACAGTTCGGGAGTGGGCGTTTCCGTGGATGAAAGCCTACAGATTGTCAACAACACTCTGGAAGTGAAACCGGATCCCAGCGGACCGCTTACGGTCTCCGCCAATGGCCTAGGGCTGAAGTACGACACTAATACCCTAGCGGTGACCGCGGGCGCTTTAACCGTGGTCGGAGGGGGGAGCGTCTCCACACCCATCGCTACTTTTGTCTCGGGAAGTCCCAGCCTCAACACCTACAATGCCACGACCGTCAATTCCAGCGCGAACGCCTTCTCTTGCGCCTACTACCTTCAACAGTGGAACATACAGGGGCTCCTTGTTACCTCCCTCTACTTGAAATTGGACAGCGCCACCATGGGGAATCGCCCTGGGGACCTCAACTCCGCCAATGCCAAATGGTTCACCTTTTGGGTGTCCGCCTATCTCCAGCAATGCAACCCCTCCGGGATTCAAGCGGGAACGGTCAGCCCCTCCACCGCCACCCTCACGGACTTTGAACCCATGGCCAATAGGAGCGTGACCAGCCCATGGACGTACTCGGCCAATGGATACTATGAACCATCCATCGGGGAATTCCAAGTGTTCAGCCCGGTGGTAACAGGTGCCTGGAACCCGGGAAACATAGGGATCCGCGTCCTCCCCGTGCCGGTTTCGGCCTCCGGAGAGCGATACACCCTTCTATGCTATAGTCTGCAGTGCACGAACGCGAGCATTTTTAATCCAAACAACAGCGGAACCATGATCGTGGGACCCGTGCTCTACAGCTGTCCAGCGGCCTCCCTCCCGTAA。
3. the recombinant avian adenovirus serotype 4 that is partially deleted from F2 according to claim 1, wherein the host proteins that interact with the F2 protein are KPNA3 and KPNA4 proteins, the gene sequences of which are shown in SEQ ID No.3 and SEQ ID No. 4;
SEQ ID NO.3 is:
ATGGCCGAGAACGCCGCCGCCGGCCTGGAGAACCACCGCATCAAGAGCTTCAAGAACAAGGGCCGCGACGTGGAGACTATGAGGAGACACAGAAACGAAGTTACAATTGAATTGAGGAAGAACAAAAGAGATGAACATCTTTTGAAAAAACGAAACGTTCCCCAAGAAGAAAGTTTAGAAGATTCTGATGTTGATGCTGACTTCAAAGCACAAAACGTAACACTAGAAGCTATACTGCAGAACGCCACAAGTGACAACCCAGTGATCCAACTGAGTGCTGTTCAAGCTGCAAGAAAACTCCTATCCAGTGACAGAAATCCACCTATTGATGACTTAATAAAATCTGGAATTTTGCCAATTCTGGTAAAATGCCTAGAAAGGGATGATAATCCTTCATTACAATTTGAAGCTGCATGGGCATTGACTAACATAGCATCAGGCACTTCTGCACAAACTCAAGCTGTTGTACAGTCTAATGCAGTACCCCTCTTTTTGAGACTACTCCATTCTCCGCACCAGAACGTTTGTGAGCAGGCTGTGTGGGCCCTCGGAAATATCATTGGTGATGGTCCTCAGTGTAGAGATTATGTCATATCACTGGGAGTTGTCAAACCTCTTCTGTCCTTCATCAATCCCTCCATTCCCATCACCTTCCTTCGGAACGTCACATGGGTCATTGTAAATCTCTGCAGGAATAAGGACCCCCCACCGCCTATGGAGACAGTTCAGGAGATTTTGCCAGCATTGTGTGTTCTCATTTACCATACAGATATAAACATTCTCGTGGACACCGTTTGGGCTTTGTCCTACTTAACAGACGGTGGCAACGAGCAGATACAGATGGTGATTGATTCGGGAGTTGTACCTTTTCTAGTTCCCCTTCTGAGTCACCAGGAGGTCAAAGTTCAGACAGCAGCACTGAGAGCAGTAGGCAACATAGTAACCGGTACCGATGAACAGACACAAGTTGTTCTCAACTGTGATGTTTTGTCTTACTTCCCAAACCTCCTGACGCATCCAAAAGAGAAGATAAACAAGGAAGCAGTTTGGTTCCTTTCCAATATCACAGCAGGAAACCAGCAACAAGTTCAGGCTGTAATAGATGCTGGGCTAATCCCTATGATCATACACCAGCTGGCTAAGGGTGACTTTGGAACACAGAAGGAAGCTGCTTGGGCAATTAGCAATTTGACAATAAGTGGGAGAAAAGATCAGGTTGAATACCTTGTACAGCAAAACGTAATCCCACCATTCTGCAATCTACTCTCAGTAAAGGATTCTCAAGTGGTGCAGGTGGTGCTGGATGGTCTGAAAAACATCCTGATAATGGCTGGTGATGAGGCTAGCACAATAGCTGAAATTATAGAAGAGTGTGGAGGGTTAGAGAAAATTGAAGCCTTGCAACAACATGAGAATGAAGACATTTATAAACTAGCGTTTGAAATCATAGATCAATATTTCTCTGGTGATGATATCGATGAGGATCCCAGTCTCATTCCTGAAGCCACTCAAGGAGGTACTTACAATTTTGACCCGACAGCCAACCTTCAAACAAAAGAATTTAATTTTTAA;
SEQ ID NO.4 is:
ATGGCCGACAACGAGAAACTGGACAACCAGCGGCTGAAGAACTTCAAGAACAAAGGCCGCGACCTGGAGACTATGAGAAGACAAAGGAATGAAGTTGTCGTGGAGTTGAGAAAGAACAAAAGAGACGAACATCTTCTAAAGAGGAGGAATGTACCCCATGAGGATATCTGTGAAGATTCCGACGTAGATGGTGACTTCAGAGTGCAAAACACTTCTTTGGAAGCAATAGTACAGAATGCTTCAAGTGACAACCAGGGTATACAGTTAAGTGCTGTGCAAGCTGCAAGAAAACTGCTTTCCAGTGATCGCAATCCACCAATTGATGATCTAATAAAATCAGGAATATTACCTATTCTAGTGCACTGTCTTGAAAGAGATGACAATCCTTCTTTACAGTTTGAAGCTGCATGGGCTTTGACAAACATTGCATCTGGAACCTCTGAACAAACACAGGCCGTGGTTCAATCTAATGCTGTACCACTTTTTCTGAGACTGCTGCATTCACCTCACCAAAATGTTTGTGAACAAGCTGTGTGGGCTTTAGGCAATATCATAGGTGATGGACCCCAGTGTAGAGATTACGTTATTAGTCTTGGAGTAGTGAAACCACTGCTGTCCTTCATCAGCCCATCTATTCCCATAACTTTCTTAAGAAACGTTACTTGGGTCATGGTCAACTTGTGCCGTCACAAAGATCCTCCTCCGCCCATGGAAACCATTCAGGAGATCCTTCCAGCCCTCTGTGTTTTAATTCACCACACAGATGTAAATATATTGGTAGATACAGTCTGGGCACTCTCATATCTAACGGATGCTGGCAATGAACAGATCCAGATGGTGATAGACTCCGGAATAGTCCCTCATTTGGTTCCTCTTCTCAGTCATCAAGAAGTGAAAGTGCAGACTGCTGCGCTGAGAGCGGTAGGAAACATTGTCACTGGTACCGATGAGCAGACACAGGTAGTTCTGAATTGTGAAGCTCTTTCACATTTCCCAGCACTTCTGACACATCCCAAAGAAAAAATTAATAAGGAAGCAGTGTGGTTTCTATCTAACATCACTGCAGGAAATCAGCAGCAAGTTCAGGCAGTAATAGATGCAAACCTTGTTCCAATGATAATACATCTTCTAGATAAGGGTGACTTTGGTACTCAGAAAGAAGCTGCTTGGGCAATAAGCAATTTAACAATCAGCGGAAGAAAAGACCAAGTGGCATACTTAATTCAACAAAACGTAATTCCTCCCTTTTGCAATTTGCTAACAGTAAAAGATGCACAAGTTGTGCAAGTGGTTCTGGATGGACTAAGTAATATATTAAAAATGGCTGAAGATGAAGCAGAAACCATAGCCAATCTTATTGAAGAGTGCGGAGGCCTGGAGAAAATTGAACAGCTACAAAACCATGAAAATGAAGACATCTACAAACTGGCTTATGAGATCATTGATCAGTTCTTCTCTTCAGATGATATTGATGAAGATCCTAGCCTTGTACCGGAAGCAATACAAGGCGGAACATTTGGTTTCAATTCATCTGCCAATGTACCAGCAGAAGGGTTCCAGTTTTAG。
4. the method for preparing the recombinant avian adenovirus serotype 4 with partial deletion of F2 according to claim 1, comprising the following steps:
(1) designing sgRNAs at the downstream positions of Fiber 1 gene and Fiber2 gene by utilizing an sgRNA online design website, and selecting the sgRNAs with higher scores and higher ranks, wherein the sequences of the sgRNAs are shown in Table 1;
TABLE 1 sgRNA sequences for Fiber 1 and Fiber2 genes
Figure FDA0002996565610000041
(2) A donor plasmid in which the Fiber2 partial gene was deleted was constructed by overlap-PCR using the primer sequences shown in Table 2;
TABLE 2 PCR sequences used for construction of Donor plasmids
Figure FDA0002996565610000051
(3) Paving LMH cells one day before transfection, transfecting two sgRNAs and donor plasmids each by 2ug on the next day, and replacing with 10% growth solution after transfecting for 6 h;
(4) infection with FAdV4-EGFP is carried out 24h after transfection, and 1% maintenance fluid is changed 2h later;
(5) after FAdV4-EGFP infection, indirect immunofluorescence and limiting dilution are used for purification, and the deletion type recombinant FAdV4 virus with a F2 partial functional region deleted is obtained.
5. The method of claim 4, wherein the LMH cell line is a chicken liver cancer cell line.
CN202110332197.9A 2021-03-29 2021-03-29 F2 partially-deleted recombinant serum type 4 avian adenovirus and preparation method thereof Pending CN113005101A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202110332197.9A CN113005101A (en) 2021-03-29 2021-03-29 F2 partially-deleted recombinant serum type 4 avian adenovirus and preparation method thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202110332197.9A CN113005101A (en) 2021-03-29 2021-03-29 F2 partially-deleted recombinant serum type 4 avian adenovirus and preparation method thereof

Publications (1)

Publication Number Publication Date
CN113005101A true CN113005101A (en) 2021-06-22

Family

ID=76408523

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202110332197.9A Pending CN113005101A (en) 2021-03-29 2021-03-29 F2 partially-deleted recombinant serum type 4 avian adenovirus and preparation method thereof

Country Status (1)

Country Link
CN (1) CN113005101A (en)

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20140010834A1 (en) * 2011-03-16 2014-01-09 University Of Guelph Non-pathogenic serotype 4 fowl adenovirus (fadv-4) and viral vector thereof
CN110607285A (en) * 2019-08-28 2019-12-24 扬州大学 Heat-resistant avian adenovirus serotype 4 genetic engineering vaccine candidate strain and construction method thereof
CN111218477A (en) * 2020-03-11 2020-06-02 中国疾病预防控制中心病毒病预防控制所 Avian type 4 adenovirus vector for targeted infection of mammalian cells and application thereof

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20140010834A1 (en) * 2011-03-16 2014-01-09 University Of Guelph Non-pathogenic serotype 4 fowl adenovirus (fadv-4) and viral vector thereof
CN110607285A (en) * 2019-08-28 2019-12-24 扬州大学 Heat-resistant avian adenovirus serotype 4 genetic engineering vaccine candidate strain and construction method thereof
CN111218477A (en) * 2020-03-11 2020-06-02 中国疾病预防控制中心病毒病预防控制所 Avian type 4 adenovirus vector for targeted infection of mammalian cells and application thereof

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
CALDWELL RB ET AL.: "NM_001007963.1", 《NCBI》 *
GABRIE1 G ET AL.: "NM_001193575.1", 《NCBI》 *
QUAN XIE ET AL.: "Domain in Fiber-2 interacted with KPNA3/4 significantly affects the replication and pathogenicity of the highly pathogenic FAdV-4", 《VIRULENCE》 *

Similar Documents

Publication Publication Date Title
CN110093324B (en) Attenuated African swine fever virus with gene deletion and application thereof as vaccine
CN108728490B (en) Baculovirus vector-based carp herpesvirus II type DNA vaccine and construction method and application thereof
US10421790B2 (en) Feline calicivirus vaccine
US9051584B2 (en) Heat-resistant newcastle disease virus live vaccine vector system and use thereof
CN113122511B (en) Attenuated African swine fever virus strain with gene deletion and construction method and application thereof
CN113061586B (en) Recombinant serum 4 type avian adenovirus for expressing serum 8 type avian adenovirus fiber protein and preparation method thereof
CN110951699B (en) Recombinant rabies virus for expressing canine distemper virus structural protein and application thereof
CN109321534A (en) A kind of recombination VIII type newcastle disease virus low virulent strain
CN111996175B (en) African swine fever attenuated and live vaccine deleted of E66L, I267L gene
CN111744000B (en) Foot-and-mouth disease recombinant virus with reduced immunosuppressive function and preparation method and application thereof
CN108101967B (en) I-group serum 4 type avian adenovirus genetic engineering subunit vaccine, preparation method and application thereof
CN111304253A (en) African swine fever virus vaccine, preparation method and application thereof
CN112877303A (en) Recombinant serum type 4 avian adenovirus expressed by fusion of EGFP and Fiber-2 and preparation method thereof
CN111548394A (en) Fowl bursa virus gene engineering vaccine and its preparation method and use
CN113005102A (en) Recombinant serum type 4 avian adenovirus with green fluorescent protein replacing Fiber-2 and preparation method thereof
CN113005101A (en) F2 partially-deleted recombinant serum type 4 avian adenovirus and preparation method thereof
Xu et al. Genomic characterization of covert mortality nodavirus from farming shrimp: Evidence for a new species within the family Nodaviridae
CN109022373B (en) Duck plague virus UL56 gene 3&#39; end deletion and LORF5 gene deletion mutant strain and construction method and application thereof
US10894081B2 (en) Recombinant bivalent inactivated vaccine against foot-and-mouth disease virus, preparation method and use thereof
WO2022163902A1 (en) Vaccine composition for preventing human infectious sars coronavirus and alleviating infection symptoms
CN109136200A (en) A kind of recombination infectious hematopoietic necrosis poison and its construction method and application
CN114292823A (en) Recombinant LaSota vaccine strain carrying genes VII type Newcastle disease virus F and HN genes and construction method and application thereof
CN113061585A (en) Recombinant serum type 4 avian adenovirus based on CRISPR-Cas9 technology and preparation method thereof
JP2013055940A (en) Recombinant novirhabdovirus and use thereof
CN113337476A (en) Foot-and-mouth disease O type Panasia-2 lineage reserve vaccine strain and construction method and application thereof

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20210622

WD01 Invention patent application deemed withdrawn after publication